Dr Reddy’s Lowers Price of Sputnik Booster
Dr Reddy’s lab said on May 19 that it would reduce the price of the Sputnik Light vaccine, which will be used as a booster...
Tag : Covaxin
Phase 2/3 Trial of Covaxin in the US On Hold: WHO
The US Food and Drug Administration (FDA) has suspended a Phase 2/3 clinical trial of Bharat Biotech’s COVID-19 vaccine Covaxin in the US According to...
Bharat Biotech Updates Covaxin Efficacy to 65.2%
Bharat Biotech has updated the efficacy of Covaxin to 65.2 per cent against the Delta variant in Effectiveness Study on Delta Variant Lancet Infectious Diseases,...
Bharat Biotech Finishes Phase 2/3 Trials of Paediatric Covaxin
Bharat Biotech has finished the Phase 2/3 trials of the Covaxin for kids under 18 years of age and will submit the data by next...
ZyCoV-D to Get Permission For Emergency Use This Week
Zydus Cadila‘s Covid-19 vaccine ZyCoV-D is getting a nod for emergency use in India by this week. Union Health Minister Mansukh Mandaviya in the Rajya...
Zydus Cadila Applies for Emergency Use of Covid-19 Vaccine
Indian drugmaker Zydus Cadila has applied to the Central Drugs Standard Control Organisation (CDSCO) for emergency use approval of its Covid-19 vaccine, which showed a...
Cipla Gets DGCI Permission to Import Moderna’s Vaccine
Cipla, a multinational pharmaceutical company headquartered in Mumbai, on Tuesday received approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine...
Covaxin to be Approved by Oct for Kids: AIIMS Chief
As the threat of the third wave of Covid-19 appears large over India, the AIIMS Chief expects approval of the Covaxin coronavirus vaccine for children...
FDA Rejects Ocugen’s Application of Covaxin
The US Food and Drug Administration (FDA) has rejected the proposal for emergency use authorization (EUA) of Bharat Biotech’s Covaxin. Ocugen, which has done a...
Ocugen Pays $15 Million to Bharat Biotech for Covaxin Rights
Ocugen Inc, the US partner for Bharat Biotech‘s Covid-19 vaccine has announced the payment of $15 million to Bharat Biotech for the vaccine rights in...